Skip to main content
Clinical Trials/NCT05446194
NCT05446194
Completed
Not Applicable

Vestibulopathy, Imbalance, and Gait Disturbances in Parkinson Disease

University of Michigan1 site in 1 country72 target enrollmentOctober 12, 2021

Overview

Phase
Not Applicable
Intervention
Non invasive neuromodulation device pattern 1
Conditions
Parkinson Disease
Sponsor
University of Michigan
Enrollment
72
Locations
1
Primary Endpoint
Freezing of Gait
Status
Completed
Last Updated
2 months ago

Overview

Brief Summary

This study investigates whether vestibular (inner ear) dysfunction is a cause for poor balance in Parkinson Disease (PD), and whether inner ear stimulation with a small device may improve balance. This study will involve clinical testing, brain imaging, and an interventional treatment device for symptoms.

Detailed Description

Basic testing of participants began in November 2021, but using the device or sham will not begin prior to July 2022.

Registry
clinicaltrials.gov
Start Date
October 12, 2021
End Date
July 24, 2025
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chatkaew Pongmala

Research Investigator

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • 1\. Parkinson disease duration of 5 years or more or Hoehn \& Yahr stage 1.5-4

Exclusion Criteria

  • History of Meniere disease or recent onset of acute vestibular dysfunction, such as otolith disorders (BBPV etc).
  • Other disorders which may resemble PD, such as progressive supranuclear palsy (PSP), vascular dementia, normal pressure hydrocephalus, multiple system atrophy (MSA), corticobasal ganglionic degeneration, or toxic causes of parkinsonism. Prototypical cases have distinctive clinical profiles, like early and severe dysautonomia (MSA) or appendicular apraxia, which may differentiate them from idiopathic PD and PSP. The use of the UKPDSBRC clinical diagnostic criteria for PD will mitigate the inclusion of subjects with atypical parkinsonism.
  • Evidence of a stroke or mass lesion on structural brain imaging (MRI).
  • Participants in whom MRI is contraindicated including, but not limited to, those with a pacemaker, presence of metallic fragments near the eyes or spinal cord, or cochlear implant.
  • Severe claustrophobia precluding MR or PET imaging.
  • Subjects limited by participation in research procedures involving ionizing radiation.
  • Pregnancy (test within 48 hours of each PET session) or breastfeeding.
  • Subjects with active and unstable mood or anxiety disorders
  • Subjects with active ear infections or perforated eardrums

Arms & Interventions

Investigational Treatment 1

Investigational treatment stimulation pattern 1

Intervention: Non invasive neuromodulation device pattern 1

Investigational Treatment 2

Investigational treatment stimulation pattern 2

Intervention: Non invasive neuromodulation device pattern 2

Outcomes

Primary Outcomes

Freezing of Gait

Time Frame: after a week of treatment

Freezing of Gait is measured by the New Freezing of Gate Questionnaire, the current gold standard for assessment of FoG in Parkinsons Disease. Measured on a scale of 0 - 28 points with higher numbers representing more severe freezing of gait

Study Sites (1)

Loading locations...

Similar Trials